Dr. Sluzevich is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4500 San Pablo Rd S
Jacksonville, FL 32224Phone+1 904-953-2000
Summary
- board certified in dermatology and dermatopathology
Education & Training
- University of Cincinnati Medical Center/College of MedicineFellowship, Dermatopathology, 2004 - 2005
- University of Cincinnati Medical Center/College of MedicineResidency, Dermatology, 2000 - 2004
- Yale School of MedicineClass of 2000
Certifications & Licensure
- FL State Medical License 2007 - 2025
- IA State Medical License 2006 - 2008
- OH State Medical License 2000 - 2006
- American Board of Dermatology Dermatology
- American Board of Dermatology Dermatopathology
Awards, Honors, & Recognition
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- Cosentyx (Secukinumab) for the Treatment of Adult Onset Pityriasis Rubra Pilaris Start of enrollment: 2018 Apr 01
- Valchlor in the Treatment of Lichen Planopilaris Start of enrollment: 2018 Apr 01
- Mepolizumab for the Treatment of Chronic Spontaneous Urticaria Start of enrollment: 2019 Jul 30
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsA Review of Oral Therapies for the Treatment of Skin Hyperpigmentation.Serena J E Shimshak, Leila M. Tolaymat, Claire B. Haga, Nancy L. Dawson, Mindy S Gillis
Journal of Cutaneous Medicine and Surgery. 2021-09-19 - 21 citationsSecukinumab for the treatment of adult-onset pityriasis rubra pilaris: a single-arm clinical trial with transcriptomic analysis.Blake W Boudreaux, Thais P Pincelli, Puneet K Bhullar, Meera H Patel, Caitlin M Brumfiel
The British Journal of Dermatology. 2022-11-01 - 59 citationsModel Combining Tumor Molecular and Clinicopathologic Risk Factors Predicts Sentinel Lymph Node Metastasis in Primary Cutaneous MelanomaDomenico Bellomo, Suzette M. Arias-Mejias, Chandru Ramana, Joel B. Heim, Enrica Quattrocchi
JCO Precision Oncology. 2020-04-14
Authored Content
- Association Between High-Grade Myelodysplastic Syndrome and Cutaneous Langerhans Cell Histiocytosis Suggested by Next-Generation SequencingMay 2020
Press Mentions
- Mayo Clinic Q and a: Treating a Rare Skin Disorder Known as MorpheaSeptember 30th, 2021
- Mayo Clinic Q and A: Bleeding Moles and Skin ChecksJuly 2nd, 2021
- Genetic Expression Testing Still a Work in Progress for MelanomaDecember 10th, 2019
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: